Wednesday, January 4, 2023

Nautilus Launches "SOBER-UP!" An Effervescent Medication That Helps Metabolize Alcohol with Silybum marianum L.

 

Nautilus Launches "SOBER-UP!" An Effervescent Medication That Helps Metabolize Alcohol with Silybum marianum L.

Richard H. Davis, President and Chief Executive Officer of Nautilus International, Inc., announced today the launch of SOBER-UP!, an effective and non-narcotic medication that helps metabolize alcohol with Silybum marianum L., which plays a critical medical role in protecting the liver from excessive alcohol abuse. Each effervescent tablet contains 250 milligrams of aspirin plus 50 milligrams of natural caffeine along with 1000 milligrams of Silybum marianum L. from Euromed S.A., a division of the German pharmaceutical firm Madaus AG.

"The liver takes about eight hours to eliminate alcohol from the bloodstream, however women are not predisposed to alcohol genetically as are men and have much lower levels of alcohol dehydrogenase, the enzyme that breaks down alcohol in the stomach and suffer from far worse effects of alcohol reduction than men," noted Davis. “Silybum marianum L. is of value in a clinical situation, it is critical to recognize if a person can improve their alertness and awareness, they can make important medical decisions since most of the alcohol is metabolized out of the body.” said Davis.

SOBER-UP! Is an effective amethystic that can help prevent alcohol from being absorbed from the stomach into the lungs, giving an incorrect Breathalyzer reading, estimating a higher than true blood alcohol content from your breath sample. SOBER-UP! Is a girl's best friend! Remember to Act Responsibly - Don't Drink & Drive.

About Nautilus International, Inc.

Nautilus International, Inc., is a beverage marketing firm located in Beverly Hills, California with the intent of accelerating the growth of the Company’s flagship product SOBER-UP! Nautilus is engaged in the private label bottled water industry. Their product brands are both licensed and developed in-house, for private label store brands or co-brands which are bottled at strategic locations throughout the United States, Canada and Europe. 

† These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

No comments:

Post a Comment

NAUTILUS LAUNCHES NICOSHOT – WORLD’S FIRST SMOKING-CESSATION BEER

  archive.is webpage capture Saved from no other snapshots from this url 30 Jun 2023 23:39:00 UTC All snapshots from host  beeralien.com Web...